These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 37954591)

  • 1. Dyslipidemia in rheumatoid arthritis: the possible mechanisms.
    Yan J; Yang S; Han L; Ba X; Shen P; Lin W; Li T; Zhang R; Huang Y; Huang Y; Qin K; Wang Y; Tu S; Chen Z
    Front Immunol; 2023; 14():1254753. PubMed ID: 37954591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profile and risks of cardiovascular diseases in conditions of rheumatoid arthritis.
    Pašková U
    Ceska Slov Farm; 2019; 68(6):219-228. PubMed ID: 31906689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.
    Curtis JR; John A; Baser O
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1282-91. PubMed ID: 22504829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High density lipoprotein in rheumatoid arthritis: emerging role in predicting inflammation level and osteoporosis occurrence.
    Zeng T; Tan L; Yu J; Wu Y
    Scand J Clin Lab Invest; 2020 Sep; 80(5):375-380. PubMed ID: 32279574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk.
    Venetsanopoulou AI; Pelechas E; Voulgari PV; Drosos AA
    Rheumatol Int; 2020 Aug; 40(8):1181-1191. PubMed ID: 32524301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
    Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
    J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment.
    Akiyama M; Mawatari T; Nakashima Y; Miyahara H; Yamada H; Okazaki K; Fukushi J; Kondo M; Kishimoto J; Hashimura C; Iwamoto Y
    Clin Rheumatol; 2015 Nov; 34(11):1867-75. PubMed ID: 26292631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors of Progression and Occurrence of Atherosclerosis in Rheumatoid Arthritis.
    Fomicheva OA; Popkova TV; Krougly LB; Gerasimova EV; Novikova DS; Pogorelova OA; Tripoten MI; Balakhonova TV; Karpov YA; Nasonov EL
    Kardiologiia; 2021 Feb; 61(1):12-21. PubMed ID: 33734051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?
    Bag-Ozbek A; Giles JT
    Curr Allergy Asthma Rep; 2015 Feb; 15(2):497. PubMed ID: 25504261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.
    Karpouzas GA; Ormseth SR; Ronda N; Hernandez E; Budoff MJ
    J Autoimmun; 2022 May; 129():102815. PubMed ID: 35366608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients.
    Behl T; Kaur I; Sehgal A; Zengin G; Brisc C; Brisc MC; Munteanu MA; Nistor-Cseppento DC; Bungau S
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.
    Seriolo B; Paolino S; Sulli A; Fasciolo D; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():414-9. PubMed ID: 16855168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.
    McInnes IB; Thompson L; Giles JT; Bathon JM; Salmon JE; Beaulieu AD; Codding CE; Carlson TH; Delles C; Lee JS; Sattar N
    Ann Rheum Dis; 2015 Apr; 74(4):694-702. PubMed ID: 24368514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
    Liao KP; Liu J; Lu B; Solomon DH; Kim SC
    Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a lack of physical activity explain the rheumatoid arthritis lipid profile?
    AbouAssi H; Connelly MA; Bateman LA; Tune KN; Huebner JL; Kraus VB; Winegar DA; Otvos JD; Kraus WE; Huffman KM
    Lipids Health Dis; 2017 Feb; 16(1):39. PubMed ID: 28187765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Risk Assessment and Therapeutic Implications in Rheumatoid Arthritis.
    Halacoglu J; Shea LA
    J Cardiovasc Transl Res; 2020 Oct; 13(5):878-890. PubMed ID: 32080804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
    Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile.
    Hurt-Camejo E; Paredes S; Masana L; Camejo G; Sartipy P; Rosengren B; Pedreno J; Vallve JC; Benito P; Wiklund O
    Arthritis Rheum; 2001 Dec; 44(12):2761-7. PubMed ID: 11762936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study.
    Hong N; Lin Y; Ye Z; Yang C; Huang Y; Duan Q; Xie S
    Front Immunol; 2022; 13():937201. PubMed ID: 36032093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
    Popa C; Netea MG; Radstake T; Van der Meer JW; Stalenhoef AF; van Riel PL; Barerra P
    Ann Rheum Dis; 2005 Feb; 64(2):303-5. PubMed ID: 15231512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.